Characteristics and Mechanisms of a Sphingolipid-associated Childhood Asthma Endotype
Authors:
- 1 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 203 (7) , 853-863
Abstract
Rationale: A link among sphingolipids, 17q21 genetic variants, and childhood asthma has been suggested, but the underlying mechanisms and characteristics of such an asthma endotype remain to be elucidated. Objectives: To study the sphingolipid-associated childhood asthma endotype using multiomic data. Methods: We used untargeted liquid chromatography–mass spectrometry plasma metabolomic profiles at the ages of 6 months and 6 years from more than 500 children in the COPSAC2010 (Copenhagen Prospective Studies on Asthma in Childhood) birth cohort focusing on sphingolipids, and we integrated the 17q21 genotype and nasal gene expression of SPT (serine palmitoyl-CoA transferase) (i.e., the rate-limiting enzyme in de novo sphingolipid synthesis) in relation to asthma development and lung function traits from infancy until the age 6 years. Replication was sought in the independent VDAART (Vitamin D Antenatal Asthma Reduction Trial) cohort. Measurements and Main Results: Lower concentrations of ceramides and sphingomyelins at the age of 6 months were associated with an increased risk of developing asthma before age 3, which was also observed in VDAART. At the age of 6 years, lower concentrations of key phosphosphingolipids (e.g., sphinganine-1-phosphate) were associated with increased airway resistance. This relationship was dependent on the 17q21 genotype and nasal SPT gene expression, with significant interactions occurring between the genotype and the phosphosphingolipid concentrations and between the genotype and SPT expression, in which lower phosphosphingolipid concentrations and reduced SPT expression were associated with increasing numbers of at-risk alleles. However, the findings did not pass the false discovery rate threshold of <0.05. Conclusions: This exploratory study suggests the existence of a childhood asthma endotype with early onset and increased airway resistance that is characterized by reduced sphingolipid concentrations, which are associated with 17q21 genetic variants and expression of the SPT enzyme.Keywords
This publication has 45 references indexed in Scilit:
- The role of gene–environment interactions in lung disease: the urgent need for the exposomeEuropean Respiratory Journal, 2020
- Neonatal Urine Metabolic Profiling and Development of Childhood AsthmaMetabolites, 2019
- Integrative analysis of the intestinal metabolome of childhood asthmaJournal of Allergy and Clinical Immunology, 2019
- An Integrative Transcriptomic and Metabolomic Study of Lung Function in Children With AsthmaChest, 2018
- Longitudinal urinary metabolomic profiling reveals metabolites for asthma development in early childhoodPediatric Allergy and Immunology, 2018
- Metabolomic profiling of lung function in Costa-Rican children with asthmaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Vitamin D prenatal programming of childhood metabolomics profiles at age 3 yThe American Journal of Clinical Nutrition, 2017
- Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseasesJournal of Allergy and Clinical Immunology, 2013
- Food allergy: Riding the second wave of the allergy epidemicPediatric Allergy and Immunology, 2011
- The Asthma EpidemicNew England Journal of Medicine, 2006